Arsenic trioxide rewires mantle cell lymphoma response to bortezomib

Arsenic trioxide rewires mantle cell lymphoma response to bortezomib

Although most of the mantle cell lymphoma (MCL) patients initially responded well to bortezomib (BTZ), the dose-dependent toxicities have greatly limited the application of BTZ to MCL. To investigate the efficacy and mechanism of arsenic trioxide (ATO) with BTZ in inducing apoptosis of MCL cells, tw...

Full description

Bibliographic Details
Main Authors: Zhao, Ling-Ling, Liu, Yuan-Fang, Peng, Li-Jun, Fei, Ai-Mei, Cui, Wen, Miao, Sheng-Chao, Hermine, Olivier, Gressin, Remy, Khochbin, Saadi, Chen, Sai-Juan, Wang, Jin, Mi, Jian-Qing
Format: Online
Language:English
Published: John Wiley & Sons, Ltd 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674002/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674002/

Similar Items